Finnish diagnostic test developer Actim has gained CE mark certification for its SARS-CoV-2 rapid antigen test for the diagnosis of acute COVID-19 infections.

The viral antigen test kit is intended for professional use to diagnose current COVID-19 infection from a nasopharyngeal swab sample. The test does not require any laboratory equipment and it delivers results in 15 minutes.

The Actim test has demonstrated 98 percent sensitivity in identifying positive samples and 100 percent specificity in identifying negative samples, the company said.